Biblio

Export 3147 results:
Author Title [ Type(Asc)] Year
Journal Article
S. C. Mallo, Ismail, Z., Pereiro, A. X., Facal, D., Lojo-Seoane, C., Campos-Magdaleno, M., and Juncos-Rabadán, O., “Assessing Mild Behavioral Impairment with the Mild Behavioral Impairment-Checklist in People with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 66, no. 1, pp. 83-95, 2018.
C. - C. Yang, Chiu, M. - J., Chen, T. - F., Chang, H. - L., Liu, B. - H., and Yang, S. - Y., “Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1323-1332, 2018.
P. Ding, Gorenflo, M. P., Zhu, X., and Xu, R., “Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study.”, J Alzheimers Dis, vol. 92, no. 3, pp. 989-1000, 2023.
J. A. Snir, Suchy, M., Bindseil, G. A., Kovacs, M., Chronik, B. A., Hudson, R. H. E., Pasternak, S. H., and Bartha, R., “An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1241-1252, 2018.
E. Grossi, Stoccoro, A., Tannorella, P., Migliore, L., and Coppedè, F., “Artificial Neural Networks Link One-Carbon Metabolism to Gene-Promoter Methylation in Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1517-22, 2016.
M. José Gil, Manzano, M. Sagrario, Cuadrado, M. Luz, Fernández, C., Góméz, E., Matesanz, C., Calero, M., and Rábano, A., “Argyrophilic Grain Pathology in Frontotemporal Lobar Degeneration: Demographic, Clinical, Neuropathological, and Genetic Features.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1109-1117, 2018.
J. C. de la Torre, “Are Major Dementias Triggered by Poor Blood Flow to the Brain? Theoretical Considerations.”, J Alzheimers Dis, vol. 57, no. 2, pp. 353-371, 2017.
S. Ben Jemaa, Romdhane, N. Attia, Bahri-Mrabet, A., Jendli, A., Le Gall, D., and Bellaj, T., “An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.”, J Alzheimers Dis, vol. 60, no. 1, pp. 11-21, 2017.
C. Yang, Huang, X., Huang, X., Mai, H., Li, J., Jiang, T., Wang, X., and Lü, T., “Aquaporin-4 and Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 2, pp. 391-402, 2016.
J. Yang, Zhang, R., Shi, C., Mao, C., Yang, Z., Suo, Z., Torp, R., and Xu, Y., “AQP4 Association with Amyloid Deposition and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 157-169, 2017.
J. Rosenberg, “Approaches to Increasing Ethical Compliance in China with Drug Trial Standards of Practice.”, J Alzheimers Dis, vol. 52, no. 3, pp. 825-7, 2016.
J. - W. Liang, Fang, Z. - Y., Huang, Y., Liuyang, Z. - Y., Zhang, X. - L., Wang, J. - L., Wei, H., Wang, J. - Z., Wang, X. - C., Zeng, J., and Liu, R., “Application of Weighted Gene Co-Expression Network Analysis to Explore the Key Genes in Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1353-1364, 2018.
H. - F. Wang, Tan, L., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Liu, Y., Wang, C., Tsai, R. M., Jia, J. - P., and Yu, J. - T., “Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.”, J Alzheimers Dis, vol. 51, no. 1, pp. 227-36, 2016.
T. B. Shea and Remington, R., “Apparent Cognitive Decline as Revealed by an Executive Function Test within a Cohort of Elderly Individuals Self-Reporting Normal Cognitive Performance.”, J Alzheimers Dis, vol. 61, no. 3, pp. 913-915, 2018.
F. Sellal, Wallon, D., Martinez-Almoyna, L., Marelli, C., Dhar, A., Oesterlé, H., Rovelet-Lecrux, A., Rousseau, S., Kourkoulis, C. E., Rosand, J., DiPucchio, Z. Y., Frosch, M., Gombert, C., Audoin, B., Miné, M., Riant, F., Frebourg, T., Hannequin, D., Campion, D., Greenberg, S. M., Tournier-Lasserve, E., and Nicolas, G., “APP Mutations in Cerebral Amyloid Angiopathy with or without Cortical Calcifications: Report of Three Families and a Literature Review.”, J Alzheimers Dis, vol. 56, no. 1, pp. 37-46, 2017.
N. Nakamura, Ohyagi, Y., Imamura, T., Yanagihara, Y. T., Iinuma, K. M., Soejima, N., Murai, H., Yamasaki, R., and Kira, J. - I., “Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1151-1161, 2017.
C. J. Smith and J Ashford, W., “Apolipoprotein ɛ4-Associated Protection Against Pediatric Enteric Infections is a Survival Advantage in Pre-Industrial Populations.”, J Alzheimers Dis, vol. 93, no. 3, pp. 907-918, 2023.
Y. Ling Chai, Yeo, H. Kai- Hui, Wang, J., Hilal, S., Ikram, M. Kamran, Venketasubramanian, N., Wong, B. - S., and Chen, C. Li- Hsian, “Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1111-8, 2016.
L. Calderón-Garcidueñas and de la Monte, S. M., “Apolipoprotein E4, Gender, Body Mass Index, Inflammation, Insulin Resistance, and Air Pollution Interactions: Recipe for Alzheimer's Disease Development in Mexico City Young Females.”, J Alzheimers Dis, vol. 58, no. 3, pp. 613-630, 2017.
T. Persson, Lattanzio, F., Calvo-Garrido, J., Rimondini, R., Rubio-Rodrigo, M., Sundström, E., Maioli, S., Sandebring-Matton, A., and Cedazo-Minguez, A., “Apolipoprotein E4 Elicits Lysosomal Cathepsin D Release, Decreased Thioredoxin-1 Levels, and Apoptosis.”, J Alzheimers Dis, vol. 56, no. 2, pp. 601-617, 2017.
M. Basta, Zaganas, I., Simos, P., Koutentaki, E., Dimovasili, C., Mathioudakis, L., Bourbouli, M., Panagiotakis, S., Kapetanaki, S., and Vgontzas, A., “Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.”, J Alzheimers Dis, vol. 79, no. 2, pp. 763-771, 2021.
S. K. Singhrao, Harding, A., Chukkapalli, S., Olsen, I., Kesavalu, L., and Crean, S. J., “Apolipoprotein E Related Co-Morbidities and Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 935-48, 2016.
E. Dorey, Bamji-Mirza, M., Najem, D., Li, Y., Liu, H., Callaghan, D., Walker, D., Lue, L. - F., Stanimirovic, D., and Zhang, W., “Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-β-Induced Inflammatory Response in vivo and in vitro.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1265-1279, 2017.
R. E. R. Slot, Van Harten, A. C., Kester, M. I., Jongbloed, W., Bouwman, F. H., Teunissen, C. E., Scheltens, P., Veerhuis, R., and van der Flier, W. M., “Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.”, J Alzheimers Dis, vol. 56, no. 2, pp. 687-697, 2017.
R. Cardoso, Lemos, C., Oliveiros, B., Almeida, M. Rosário, Baldeiras, I., Pereira, C. Fragão, Santos, A., Duro, D., Vieira, D., Santana, I., and Oliveira, C. Resende, “APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.”, J Alzheimers Dis, vol. 78, no. 2, pp. 587-601, 2020.

Pages